estrone and Local Neoplasm Recurrence
estrone has been researched along with Local Neoplasm Recurrence in 11 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"To compare the efficacy, safety and tolerability of letrozole, an advanced non-steroidal aromatase inhibitor, and fadrozole hydrochloride, an older-generation drug in this class, we conducted a randomised double-blind trial in postmenopausal women with advanced breast cancer." | 9.10 | Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer. ( Adachi, I; Ikeda, T; Ohashi, Y; Sasaki, Y; Suwa, T; Tabei, T; Takatsuka, Y; Toi, M; Tominaga, T, 2003) |
"About one third of unselected postmenopausal women with advanced breast cancer respond to treatment with aminoglutethimide and hydrocortisone, but they all eventually relapse, and further progression of disease occurs." | 7.67 | Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy. ( Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE, 1984) |
" While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 6.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
"To compare the efficacy, safety and tolerability of letrozole, an advanced non-steroidal aromatase inhibitor, and fadrozole hydrochloride, an older-generation drug in this class, we conducted a randomised double-blind trial in postmenopausal women with advanced breast cancer." | 5.10 | Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer. ( Adachi, I; Ikeda, T; Ohashi, Y; Sasaki, Y; Suwa, T; Tabei, T; Takatsuka, Y; Toi, M; Tominaga, T, 2003) |
"About one third of unselected postmenopausal women with advanced breast cancer respond to treatment with aminoglutethimide and hydrocortisone, but they all eventually relapse, and further progression of disease occurs." | 3.67 | Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy. ( Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE, 1984) |
" While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 2.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
Research
Studies (11)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (54.55) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors
Authors | Studies |
---|---|
Matei, D | 1 |
Schilder, J | 1 |
Sutton, G | 1 |
Perkins, S | 1 |
Breen, T | 1 |
Quon, C | 1 |
Sidor, C | 1 |
Slomovitz, BM | 1 |
Filiaci, VL | 1 |
Walker, JL | 1 |
Taub, MC | 1 |
Finkelstein, KA | 1 |
Moroney, JW | 1 |
Fleury, AC | 1 |
Muller, CY | 1 |
Holman, LL | 1 |
Copeland, LJ | 1 |
Miller, DS | 1 |
Coleman, RL | 1 |
Ingle, JN | 1 |
Kalari, KR | 1 |
Barman, P | 1 |
Shepherd, LE | 1 |
Ellis, MJ | 1 |
Goss, PE | 1 |
Buzdar, AU | 1 |
Robson, ME | 1 |
Cairns, J | 1 |
Carlson, EE | 1 |
Eyman Casey, A | 1 |
Hoskin, TL | 1 |
Goodnature, BA | 1 |
Haddad, TC | 1 |
Goetz, MP | 1 |
Weinshilboum, RM | 1 |
Wang, L | 1 |
Tominaga, T | 1 |
Adachi, I | 1 |
Sasaki, Y | 1 |
Tabei, T | 1 |
Ikeda, T | 1 |
Takatsuka, Y | 1 |
Toi, M | 1 |
Suwa, T | 1 |
Ohashi, Y | 1 |
Dowsett, M | 1 |
Harris, AL | 1 |
Smith, IE | 1 |
Jeffcoate, SL | 1 |
Jalůvka, V | 1 |
Kratzsch, E | 1 |
Bonte, J | 1 |
Ide, P | 1 |
Billiet, G | 1 |
Wynants, P | 1 |
Wada, T | 1 |
Nomura, Y | 1 |
Oohashi, Y | 1 |
Abe, O | 1 |
Koyama, H | 1 |
Takashima, S | 1 |
Santen, RJ | 1 |
Samojlik, E | 1 |
Lipton, A | 1 |
Harvey, H | 1 |
Ruby, EB | 1 |
Wells, SA | 1 |
Kendall, J | 1 |
Kalavathi, N | 1 |
Grönroos, M | 1 |
Aho, AJ | 1 |
Reviews
2 reviews available for estrone and Local Neoplasm Recurrence
Article | Year |
---|---|
[Hormone activity of various Brenner tumors].
Topics: Aged; Breast Neoplasms; Brenner Tumor; Estradiol; Estrone; Female; Humans; Neoplasm Metastasis; Neop | 1982 |
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehy | 1977 |
Trials
4 trials available for estrone and Local Neoplasm Recurrence
Article | Year |
---|---|
Activity of 2 methoxyestradiol (Panzem NCD) in advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis: a Hoosier Oncology Group trial.
Topics: 2-Methoxyestradiol; Adult; Aged; Antineoplastic Agents; CA-125 Antigen; Disease-Free Survival; Drug | 2009 |
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Endometrial Neoplasms; Estradiol; | 2022 |
Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer.
Topics: Administration, Oral; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease Progres | 2003 |
[Late phase II study of CGS16949A, a new aromatase inhibitor--a multicentral cooperative study (Western Japan Group)].
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Estradiol; Estron | 1994 |
Other Studies
5 other studies available for estrone and Local Neoplasm Recurrence
Article | Year |
---|---|
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Topics: Adult; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Female; Genetic Pred | 2021 |
Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Fe | 1984 |
Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinoma.
Topics: Adenocarcinoma; Cells, Cultured; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing | 1981 |
Granulosa cell tumour--hormonal aspects and radiosensitivity.
Topics: Abdominal Neoplasms; Adult; Aged; Estradiol; Estriol; Estrogens; Estrone; Female; Gold Isotopes; Gon | 1971 |
Estrogen metabolism in postmenopausal women with primary and recurrent breast cancer.
Topics: Aging; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle A | 1968 |